Dr. Mok on the Utility of Afatinib in Lung Cancer Targeted Oncology 1:53 10 years ago 1 011 Скачать Далее
Dr. Mok on Dacomitinib for First-Line Lung Cancer Treatment OncLive 0:44 6 years ago 924 Скачать Далее
Dr. Mok Discusses Updated Data With Pembrolizumab in NSCLC OncLive 2:12 5 years ago 1 413 Скачать Далее
Dr. Mok on Improving Lung Cancer Drug Development Targeted Oncology 1:38 11 years ago 652 Скачать Далее
Dr. Mok on Overall Survival Data From the ALEX Trial in ALK+ Lung Cancer OncLive 1:02 4 years ago 539 Скачать Далее
Dr. Mok Gives an Overview of Plasma Testing Approaches for Lung Cancer Targeted Oncology 0:59 10 years ago 155 Скачать Далее
Dr. Tolba on the Use of Afatinib in NRG1-Mutated Lung Adenocarcinoma OncLive 1:59 4 years ago 185 Скачать Далее
Dr. Mok Discusses Next Steps for Pembrolizumab in NSCLC Targeted Oncology 1:38 5 years ago 398 Скачать Далее
How, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR positive NSCLC HMP Education 17:27 7 years ago 5 459 Скачать Далее
Afatinib treatment in squamous cell lung cancer – Video abstract [ID 104177] Dove Medical Press 4:24 7 years ago 3 267 Скачать Далее
Afatinib Plus Cetuximab in Resistant Non-Small Cell Lung Cancer OncLive 8:38 9 years ago 1 236 Скачать Далее
Full Interview: Dr. Tony Mok shared his perspective on LUX-Lung 7 - ESMO 2015 NE Live 9:59 8 years ago 1 760 Скачать Далее
Dr. Fidler on the Utility of Dacomitinib in EGFR-Mutant NSCLC OncLive 1:34 4 years ago 192 Скачать Далее
Dr. Langer on Afatinib for Advanced Non-Small Cell Lung Cancer OncLive 1:30 9 years ago 488 Скачать Далее
Dr. Chachoua on Afatinib for Exon 19 Mutation in Lung Cancer OncLive 1:25 9 years ago 573 Скачать Далее
